| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | February, 2003  Vol. 35  No.1 Previous Issue | Next Issue | Archive
In this issue:


Editorial
1 Molecular Markers in Gastric Cancer: Can They Predict Prognosis?
Seok Jin Kim, Yeul Hong Kim
Cancer Res Treat. 2003;35(1):1-2.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.1
      
Original Articles
3 The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer
Chang Hak Yoo, Sung Hoon Noh
Cancer Res Treat. 2003;35(1):3-8.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.3
         Cited By 2
9 Overexpression of c-met Protein in Gastric Cancer and Role of uPAR as a Therapeutic Target
Hyun A Oh, Gu Lee, Hee Jung Kang, Yong Gil Kim, Sung Hwa Bae, Jae Lyun Lee, Kyung Hee Lee, Myung Soo Hyun, Dong Suk Kim
Cancer Res Treat. 2003;35(1):9-15.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.9
         Cited By 3
16 RImmunohistochemical Evaluation of E-cadherin/catenin (alpha-, beta-, gamma-catenin and p120CTN) Complex Expression in Early Gastric Cancer
Tae Yong Jo, Tae Yong Jeon, Kyu Hwang Chae, Dong Heon Kim, Moon Sup Sim, Do Youn Park, Kang Seuk Suh
Cancer Res Treat. 2003;35(1):16-24.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.16
         Cited By 2
25 Phase I and Pharmacokinetic Study of Intraoperative Intraperitoneal Heptaplatin in Patients with Surgically Resected Advanced Gastric Cancer
Wansik Yu, Ho Young Chung, So Hyang Park, Yong Baik Cho, Yang Soo Lim
Cancer Res Treat. 2003;35(1):25-29.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.25
      
30 A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer
Se Hoon Lee, Keunchil Park, Cheolwon Suh, Hoon Kyo Kim, Jun Suk Kim, Young Hyuck Im, Sang We Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
Cancer Res Treat. 2003;35(1):30-34.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.30
         Cited By 4
35 The Estimation of Breast Cancer Disease-Probability by Difference of Individual Susceptibility
Sue Kyung Park, Keun Young Yoo, Dae Hee Kang, Sei Hyun Ahn, Dong Young Noh, Kuk Jin Choe
Cancer Res Treat. 2003;35(1):35-51.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.35
         Cited By 12
52 The Effect of More Aggressive Surgery in Esophageal Cancer
Jae Kil Park, Ihl Bohng Choi
Cancer Res Treat. 2003;35(1):52-58.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.52
      
59 Correlation between Retinoic Acid Sensitivity and IGFBP-3, AFP Protein Expression in Hepatoma Cell Lines
Hae Yun Jung, Yong Myung Lee, Young Do Yoo, Jun Suk Kim, Sun Hee Park, Yeul Hong Kim
Cancer Res Treat. 2003;35(1):59-65.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.59
      
66 The Efficacy and Safety of DA-3030 (Recombinant Human Granulocyte Colony-Stimulating Factor) in Neutropenia after the Remission Induction Chemotherapy in Patients with Acute Myelogenous Leukemia
Young Joo Min, Cheol Won Suh, Keon Uk Park, Sung Soo Yoon, Chan Hyung Park, Hong Ghi Lee
Cancer Res Treat. 2003;35(1):66-68.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.66
      
69 Clinical Experience in Conformal Stereotactic Radiotherapy of Irregularly Shaped Intracranial Tumors
Ki Hwan Kim, Moon June Cho, Dong Wuk Kim, Jun Sang Kim, Seon Hwan Kim, Chang Joon Song, Shi Hun Song, Ji Young Jang, Jae Sung Kim
Cancer Res Treat. 2003;35(1):69-74.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.69
         Cited By 1
75 Site-Specific Mutagenesis in Escherichia coli by Bulky Exocyclic Amino-Substituted Guanine and Adenine Derivatives in Double-Stranded or Gapped Plasmids
Ki Young Moon
Cancer Res Treat. 2003;35(1):75-80.   Published online February 28, 2003    DOI: https://doi.org/10.4143/crt.2003.35.1.75
         Cited By 1
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Cancer Research and Treatment 2017; 49(4): 915-926.
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community